Sedation Of Adult Patients Undergoing Gastrointestinal Endoscopy: A Network Meta-analysis

Pfizer

Status

Completed

Conditions

Gastrointestinal Endoscopy

Dexmedetomidine

Sedation

Treatments

Drug: Midazolam/Propofol

Drug: Propofol

Drug: Dexmedetomidine

Drug: Midazolam

Study type

Observational

Funder types

Industry

Identifiers

NCT03632330

C0801043

Details and patient eligibility

About

The objective of this study is to compare the efficacy and safety of dexmedetomidine with other sedatives in sedation during endoscopy by analyzing the most recently published interventional trials and observational studies.

Full description

A variety of sedatives are available in procedural sedation and the efficacy & safety have been compared in several trials for procedural sedation. However, none of clinical trial has enough number of patients to clarify the conclusive differences among sedatives. Thus, pooling all available studies together systematically by network meta-analysis for GI endoscopic procedure may provide a better understanding of efficacy and safety of sedatives. Therefore we would like to conduct a network meta-analysis to analyze the outcomes of GI endoscopy by using the most recently-published interventional trials.

Enrollment

6,963 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria We will include studies if they (1) the setting was using any sedative for endoscopy for an procedural sedation (2) the study compared dexmedetomidine with other sedative for sedative therapy and (3) the outcomes included satisfaction score and adverse events.
Exclusion criteria We excluded studies if they (1) the number of sedative was different in two arms (2) did not report the specific results comparing dexmedetomidine with other sedatives.